HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louis M Staudt Selected Research

Ligands

4/2024Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells.
12/2023TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance.
7/2012Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.
3/2011MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
6/2010Oncogenic activation of NF-kappaB.
11/2005Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louis M Staudt Research Topics

Disease

81Neoplasms (Cancer)
05/2024 - 01/2002
53Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024 - 04/2002
39Lymphoma (Lymphomas)
04/2024 - 07/2002
18B-Cell Lymphoma (Lymphoma, B Cell)
12/2021 - 12/2002
13Burkitt Lymphoma (Burkitt's Lymphoma)
04/2024 - 06/2006
9Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 11/2005
7Disease Progression
10/2021 - 07/2002
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 07/2002
6Multiple Myeloma
01/2021 - 08/2007
5Leukemia
05/2017 - 07/2002
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2022 - 05/2014
3Genetic Translocation (Chromosomal Translocation)
12/2021 - 12/2002
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2021 - 01/2007
3Carcinogenesis
11/2009 - 04/2006
2Aspergillosis
05/2024 - 12/2017
2Anemia
01/2021 - 08/2017
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2019 - 05/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016 - 06/2003
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2013 - 08/2012
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
05/2013 - 08/2012
2Hematologic Neoplasms (Hematological Malignancy)
04/2012 - 05/2006
2Hodgkin Disease (Hodgkin's Disease)
03/2011 - 03/2010
2Plasmacytoma
11/2005 - 09/2005
2Infections
08/2004 - 04/2004
1Systemic Scleroderma (Systemic Sclerosis)
12/2023

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2002
16NF-kappa B (NF-kB)IBA
09/2010 - 07/2002
14Rituximab (Mabthera)FDA Link
04/2024 - 01/2007
12ibrutinibIBA
12/2021 - 02/2014
10DNA (Deoxyribonucleic Acid)IBA
10/2018 - 01/2002
9Prednisone (Sone)FDA LinkGeneric
01/2021 - 12/2011
9Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2011
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 12/2011
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2011
8AntigensIBA
10/2021 - 01/2002
8Biomarkers (Surrogate Marker)IBA
05/2017 - 05/2003
7Agammaglobulinaemia Tyrosine KinaseIBA
05/2024 - 04/2015
7Transcription Factors (Transcription Factor)IBA
10/2018 - 05/2006
7Complementary DNA (cDNA)IBA
08/2007 - 04/2002
6LigandsIBA
04/2024 - 11/2005
6ParaffinIBA
05/2017 - 06/2011
6Phosphotransferases (Kinase)IBA
04/2016 - 06/2010
5Cyclin D1IBA
01/2021 - 02/2003
5CyclinsIBA
01/2021 - 12/2005
5Formaldehyde (Formol)FDA Link
05/2017 - 06/2011
5Messenger RNA (mRNA)IBA
01/2013 - 02/2003
4Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
04/2024 - 02/2014
4ChromatinIBA
01/2021 - 01/2012
4carboxyl radical (COO-)IBA
01/2021 - 06/2011
4Interleukin-6 (Interleukin 6)IBA
01/2020 - 09/2005
4Etoposide (VP 16)FDA LinkGeneric
01/2019 - 04/2013
4Immunoglobulin M (IgM)IBA
11/2015 - 04/2004
4MicroRNAs (MicroRNA)IBA
02/2015 - 09/2008
4RNA (Ribonucleic Acid)IBA
01/2013 - 08/2010
4Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2005 - 06/2003
3Polysaccharides (Glycans)IBA
04/2024 - 10/2021
3UbiquitinIBA
12/2021 - 04/2014
3Lenalidomide (CC 5013)FDA Link
01/2021 - 06/2012
3Histones (Histone)IBA
01/2021 - 12/2010
3AntibodiesIBA
01/2019 - 10/2014
3Immunoglobulins (Immunoglobulin)IBA
02/2014 - 12/2002
3Bortezomib (Velcade)FDA Link
08/2012 - 06/2009
3I-kappa B KinaseIBA
06/2010 - 01/2005
3Cyclin D2IBA
11/2009 - 02/2004
2EpitopesIBA
04/2024 - 10/2014
2AutoantigensIBA
01/2023 - 11/2015
2Circulating Tumor DNAIBA
11/2022 - 01/2016
2Mechanistic Target of Rapamycin Complex 1IBA
10/2022 - 10/2021
2Ligases (Synthetase)IBA
12/2021 - 01/2015
2Histocompatibility Antigens Class IIBA
12/2021 - 01/2019
2Immunoglobulin Variable RegionIBA
10/2021 - 01/2019
2Protein Isoforms (Isoforms)IBA
01/2021 - 01/2021
2Cyclin D3IBA
10/2020 - 12/2005
2Anaplastic Lymphoma KinaseIBA
11/2019 - 05/2014
2Cytidine DeaminaseIBA
01/2019 - 03/2007
2Interleukin-10 (Interleukin 10)IBA
11/2016 - 04/2008
2Small Interfering RNA (siRNA)IBA
04/2016 - 11/2012
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2013 - 11/2009
2InterleukinsIBA
05/2013 - 02/2003
2ElementsIBA
11/2012 - 11/2009
2Tetracycline (Achromycin)FDA LinkGeneric
11/2012 - 05/2009
2InterferonsIBA
06/2012 - 04/2007
2MHC class II transactivator proteinIBA
03/2011 - 11/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2009 - 01/2008
2Antigen Receptors (Antigen Receptor)IBA
03/2009 - 03/2008
1src-Family KinasesIBA
04/2024
1N-Acetylneuraminic Acid (Sialic Acid)IBA
04/2024
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2024
1polatuzumab vedotinIBA
04/2024
1GlucocorticoidsIBA
04/2024
1GlycosyltransferasesIBA
04/2024
1ChemokinesIBA
12/2023
1Janus Kinase InhibitorsIBA
10/2023
1Complement System Proteins (Complement)IBA
11/2022
1eprenetapoptIBA
10/2022
1palbociclibIBA
10/2022

Therapy/Procedure

30Therapeutics
01/2023 - 02/2003
9Drug Therapy (Chemotherapy)
01/2019 - 06/2002
7Precision Medicine
04/2024 - 01/2017
1Complementary Therapies (Alternative Medicine)
11/2022